Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 439

1.

[Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].

Cesur S, Irmak H, Simşek H, Cöplü N, Kılıç H, Arslan U, Bayramoğlu G, Baysan BO, Gülay Z, Hoşoğlu S, Berktaş M, Gencer S, Demiröz AP, Esen B, Karabiber N, Aydın F, Yalçın AN.

Mikrobiyol Bul. 2012 Jul;46(3):352-8. Turkish.

PMID:
22951647
2.

[Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].

Çıkman A, Aydın M, Gülhan B, Parlak M, Gültepe B, Kalaycı Y, Bayındır Bilmen F, Solmaz S, Özekinci T.

Mikrobiyol Bul. 2015 Apr;49(2):240-8. Turkish.

3.

[Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].

Pelitli TS, Cesur S, Kınıklı S, Irmak H, Demiröz AP, Karakoç E.

Mikrobiyol Bul. 2011 Oct;45(4):758-61. Turkish.

PMID:
22090309
4.

[Staphylococcus aureus and antibiotic resistance].

Sancak B.

Mikrobiyol Bul. 2011 Jul;45(3):565-76. Review. Turkish.

PMID:
21935792
5.

[In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin].

Celikbilek N, Ozdem B, Gürelik FC, Güvenman S, Güner HR, Açıkgöz ZC.

Mikrobiyol Bul. 2011 Jul;45(3):512-8. Turkish.

PMID:
21935784
6.

In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.

Kao TM, Wang JT, Weng CM, Chen YC, Chang SC.

J Microbiol Immunol Infect. 2011 Oct;44(5):346-51. doi: 10.1016/j.jmii.2011.01.037. Epub 2011 Jan 20.

7.

[Investigation of reduced vancomycin susceptibility in methicillin-resistant staphylococci].

Kuşcu F, Oztürk DB, Gürbüz Y, Tütüncü EE, Sencan I, Gül S.

Mikrobiyol Bul. 2011 Apr;45(2):248-57. Turkish.

PMID:
21644067
8.
9.

Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.

Farrell DJ, Flamm RK, Sader HS, Jones RN.

Int J Antimicrob Agents. 2014 Apr;43(4):323-7. doi: 10.1016/j.ijantimicag.2013.11.005. Epub 2013 Dec 11.

PMID:
24411474
10.

A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.

Cojutti P, Scarparo C, Sartor A, Coato P, Rigoli R, Pea F.

Diagn Microbiol Infect Dis. 2015 Jan;81(1):53-6. doi: 10.1016/j.diagmicrobio.2014.09.016. Epub 2014 Sep 28.

PMID:
25301716
12.

Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.

Baysallar M, Kilic A, Aydogan H, Cilli F, Doganci L.

Int J Antimicrob Agents. 2004 May;23(5):510-2. Erratum in: Int J Antimicrob Agents. 2005 Jan;25(1):93.

PMID:
15120733
13.

Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.

Patel N, Lubanski P, Ferro S, Bonafede M, Harrington S, Evans A, Stellrecht K, Lodise TP.

Antimicrob Agents Chemother. 2009 Dec;53(12):5141-4. doi: 10.1128/AAC.00307-09. Epub 2009 Oct 5.

14.

In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus.

Saravolatz LD, Pawlak J, Johnson L, Bonilla H, Saravolatz LD 2nd, Fakih MG, Fugelli A, Olsen WM.

Antimicrob Agents Chemother. 2012 Aug;56(8):4478-82. doi: 10.1128/AAC.00194-12. Epub 2012 May 14.

16.
17.

Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011.

Hanaki H, Cui L, Ikeda-Dantsuji Y, Nakae T, Honda J, Yanagihara K, Takesue Y, Matsumoto T, Sunakawa K, Kaku M, Tomono K, Fukuchi K, Kusachi S, Mikamo H, Takata T, Otsuka Y, Nagura O, Fujitani S, Aoki Y, Yamaguchi Y, Tateda K, Kadota J, Kohno S, Niki Y.

J Infect Chemother. 2014 Sep;20(9):527-34. doi: 10.1016/j.jiac.2014.06.012. Epub 2014 Jul 22.

PMID:
25066429
18.

[In vitro activity of tigecycline against methicillin-resistant staphylococci].

Tunçkanat F, Saribaş Z, Ercis S.

Mikrobiyol Bul. 2009 Apr;43(2):211-5. Turkish.

PMID:
19621605
20.

Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.

Sader HS, Jones RN, Rossi KL, Rybak MJ.

J Antimicrob Chemother. 2009 Nov;64(5):1024-8. doi: 10.1093/jac/dkp319. Epub 2009 Sep 10.

PMID:
19744978

Supplemental Content

Support Center